Asset Details
Do you wish to reserve the book?
The T7-Related Pseudomonas putida Phage φ15 Displays Virion-Associated Biofilm Degradation Properties
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
The T7-Related Pseudomonas putida Phage φ15 Displays Virion-Associated Biofilm Degradation Properties
Do you wish to request the book?
The T7-Related Pseudomonas putida Phage φ15 Displays Virion-Associated Biofilm Degradation Properties
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
The T7-Related Pseudomonas putida Phage φ15 Displays Virion-Associated Biofilm Degradation Properties
2011
Overview
Formation of a protected biofilm environment is recognized as one of the major causes of the increasing antibiotic resistance development and emphasizes the need to develop alternative antibacterial strategies, like phage therapy. This study investigates the in vitro degradation of single-species Pseudomonas putida biofilms, PpG1 and RD5PR2, by the novel phage ϕ15, a 'T7-like virus' with a virion-associated exopolysaccharide (EPS) depolymerase. Phage ϕ15 forms plaques surrounded by growing opaque halo zones, indicative for EPS degradation, on seven out of 53 P. putida strains. The absence of haloes on infection resistant strains suggests that the EPS probably act as a primary bacterial receptor for phage infection. Independent of bacterial strain or biofilm age, a time and dose dependent response of ϕ15-mediated biofilm degradation was observed with generally a maximum biofilm degradation 8 h after addition of the higher phage doses (10(4) and 10(6) pfu) and resistance development after 24 h. Biofilm age, an in vivo very variable parameter, reduced markedly phage-mediated degradation of PpG1 biofilms, while degradation of RD5PR2 biofilms and ϕ15 amplification were unaffected. Killing of the planktonic culture occurred in parallel with but was always more pronounced than biofilm degradation, accentuating the need for evaluating phages for therapeutic purposes in biofilm conditions. EPS degrading activity of recombinantly expressed viral tail spike was confirmed by capsule staining. These data suggests that the addition of high initial titers of specifically selected phages with a proper EPS depolymerase are crucial criteria in the development of phage therapy.
Publisher
Public Library of Science,Public Library of Science (PLoS)
Subject
/ Bacteria
/ Bacterial Capsules - metabolism
/ Biofilms
/ Biology
/ E coli
/ Phages
/ Plaques
/ Pseudomonas Phages - genetics
/ Pseudomonas Phages - metabolism
/ Pseudomonas putida - physiology
/ Pseudomonas putida - virology
/ Therapy
/ Viral Tail Proteins - chemistry
/ Viral Tail Proteins - metabolism
/ Virions
/ Viruses
